Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users.
暂无分享,去创建一个
R Power | M Hellard | M. Hellard | J. Lewis | R. Power | L. Topp | L. Maher | M. Jauncey | A. Conroy | R Dwyer | L Topp | L Maher | N Walsh | M Jauncey | A Conroy | J Lewis | C Aitken | N. Walsh | C. Aitken | R. Dwyer | Margaret Hellard | Lisa Maher | J. Lewis | Campbell Aitken | Robyn Dwyer | Robert Power | Nicholas Matthew Walsh | Marianne Jauncey
[1] R. Hogg,et al. Prevalence and correlates of abscesses among a cohort of injection drug users , 2005, Harm reduction journal.
[2] D. Cranston,et al. Patients in methadone maintenance treatment who inject methadone syrup: a preliminary study. , 2000, Drug and alcohol review.
[3] B. Edlin,et al. Soft tissue infections among injection drug users--San Francisco, California, 1996-2000. , 2001, MMWR. Morbidity and mortality weekly report.
[4] M. Crossley. Temperate pyomyositis in an injecting drug misuser. A difficult diagnosis in a difficult patient , 2003, Emergency medicine journal : EMJ.
[5] R. Macrae,et al. Gendered power dynamics and HIV risk in drug-using sexual relationships , 2000, AIDS care.
[6] T. Templin,et al. Chronic venous insufficiency in persons with a history of injection drug use. , 2001, Research in nursing & health.
[7] B. Edlin,et al. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] T. Rhodes,et al. Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. , 2006, Addiction.
[9] P. Giudice. Cutaneous complications of intravenous drug abuse. , 2004 .
[10] A. Morrison,et al. Injecting-related harm and treatment-seeking behaviour among injecting drug users. , 1997, Addiction.
[11] P. Allen,et al. Fungal endophthalmitis in intravenous drug users injecting buprenorphine contaminated with oral Candida species , 2005, The Medical journal of Australia.
[12] D. Looke,et al. Role of the lemon in disseminated candidiasis of heroin abusers , 1984, The Medical journal of Australia.
[13] N. Clark,et al. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? , 2005, Addiction.
[14] J. Tsao,et al. Presentation, Diagnosis, and Management of Arterial Mycotic Pseudoaneurysms in Injection Drug Users , 2002, Annals of vascular surgery.
[15] N. Cassoux,et al. Presumed ocular candidiasis in drug misusers after intravenous use of oral high dose buprenorphine (Subutex) , 2002, The British journal of ophthalmology.
[16] G. Feeney,et al. Digit loss following misuse of temazepam , 2002, The Medical journal of Australia.
[17] D. Goldberg,et al. Update: Clostridium novyi and unexplained illness among injecting-drug users--Scotland, Ireland, and England, April-June 2000. , 2000, MMWR. Morbidity and mortality weekly report.
[18] L. Topp,et al. Prevalence and predictors of injecting‐related injury and disease among clients of Australia's needle and syringe programs , 2008, Australian and New Zealand journal of public health.
[19] D. Vugia,et al. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] R. Bruno,et al. Tasmanian Drug Trends 2015. Findings from the Illicit Drug Reporting System (IDRS) , 2000 .
[21] G. Pawelec. Immunity and ageing in man , 2006, Experimental Gerontology.
[22] J. Montaner,et al. Changes in injecting practices associated with the use of a medically supervised safer injection facility. , 2007, Journal of public health.
[23] B. Lloyd,et al. Qld Drug Trends 2006: Findings from the Illicit Drug Reporting System (IDRS) , 2003 .
[24] D. O’Briain,et al. Autopsy findings in an outbreak of severe systemic illness in heroin users following injection site inflammation: an effect of Clostridium novyi exotoxin? , 2003, Archives of pathology & laboratory medicine.
[25] Shane Darke,et al. The injection of methadone and benzodiazepines among Sydney injecting drug users 1996-2000: 5-year monitoring of trends from the Illicit Drug Reporting System. , 2002, Drug and alcohol review.
[26] T. Rhodes,et al. Groin injecting in the context of crack cocaine and homelessness: From ‘risk boundary’ to ‘acceptable risk’? , 2006 .
[27] A. Ritter,et al. Paying research participants: a study of current practices in Australia , 2005, Journal of Medical Ethics.
[28] S. Darke,et al. Physical injecting sites among injecting drug users in Sydney, Australia. , 2001, Drug and alcohol dependence.
[29] L. Maher,et al. Risk behaviours of young Indo‐Chinese injecting drug users in Sydney and Melbourne , 2001, Australian and New Zealand journal of public health.
[30] J. Murie,et al. Vascular complications of injecting drug misuse , 1996, The British journal of surgery.
[31] G. Feeney,et al. Groin tissue necrosis requiring skin graft following parenteral abuse of buprenorphine tablets. , 2003, Drug and alcohol review.
[32] P. Higgs,et al. Vulnerability among Vietnamese illicit drug users in Australia: challenges for change , 2002 .
[33] S. Allsop,et al. Managing alcohol‐related problems among Indigenous Australians: what the literature tells us , 2010, Australian and New Zealand journal of public health.
[34] J. Brazier,et al. Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom , 2005, Epidemiology and Infection.
[35] R. Coutinho,et al. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. , 1996, Journal of clinical epidemiology.
[36] D. Passaro,et al. Wound botulism associated with black tar heroin among injecting drug users. , 1998, JAMA.
[37] N. Hunt,et al. The safer injecting briefing: an easy to use comprehensive reference guide to promoting safer injecting. , 1998 .